Interpace Biosciences, Inc. Share Price
Stocks
IDXG
US46062X3035
Healthcare Facilities & Services
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.450 USD | -3.97% |
|
-10.49% | +17.87% |
| Market Cap | 41.83M 36.77M 34.16M 31.42M 58.89M 4.04B 60.04M 408M 159M 1.98B 157M 154M 6.85B | P/E 2024 |
6.84x | P/E 2025 | 1.39x |
|---|---|---|---|---|---|
| Enterprise Value | 40.51M 35.6M 33.08M 30.43M 57.03M 3.91B 58.14M 395M 154M 1.91B 152M 149M 6.63B | EV / Sales 2024 |
0.35x | EV / Sales 2025 | 0.11x |
| Free-Float |
14.74% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -3.97% | ||
| 1 week | -10.49% | ||
| Current month | -11.04% | ||
| 1 month | -11.04% | ||
| 3 months | -27.41% | ||
| 6 months | -16.18% | ||
| Current year | +17.87% |
| 1 week | 1.34 |  | 1.57 |
| 1 month | 1.34 | | 1.8 |
| Current year | 1.03 | | 2.4 |
| 1 year | 0.77 | | 2.4 |
| 3 years | 0.44 | | 3.54 |
| 5 years | 0.44 | | 10.5 |
| 10 years | 0.44 | | 198 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Burnell
CEO | Chief Executive Officer | 64 | 30/11/2020 |
| Director of Finance/CFO | 34 | 20/04/2023 | |
Nicole Massoll
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Sullivan
CHM | Chairman | 79 | 20/06/2016 |
Joseph Keegan
BRD | Director/Board Member | 73 | 31/12/2015 |
Fortunato Rocca
BRD | Director/Board Member | 64 | 21/01/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 20/01/26 | Ampersand Management LLC
| Conversion | Company | 13,861,386 | 313.0013% | |
| 20/01/26 | 1315 Capital LLC
| Conversion | Company | 9,405,941 | 212.3938% | |
| 01/02/24 | Free | Chief Financial Officer | 10,000 | 0.2314% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.97% | -10.49% | +47.96% | -33.49% | 41.83M | |
| +0.18% | -4.57% | +89.17% | +436.79% | 37.84B | |
| +3.40% | +7.00% | +15.45% | +32.76% | 23.08B | |
| 0.00% | -3.17% | -24.50% | -41.14% | 7.19B | |
| +2.97% | -0.70% | +6.72% | +74.28% | 4.66B | |
| -0.70% | -2.10% | +12.32% | +47.54% | 2.94B | |
| +1.64% | -1.79% | +121.81% | -18.35% | 1.82B | |
| +1.25% | -4.17% | -21.66% | +703.30% | 1.86B | |
| -2.18% | -5.42% | -8.99% | -62.78% | 1.85B | |
| +7.66% | +0.97% | +14.27% | +5.81% | 1.79B | |
| Average | +1.02% | -2.39% | +25.26% | +114.47% | 8.31B | |
| Weighted average by Cap. | +1.35% | -1.88% | +45.92% | +224.38% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 46.93M 41.25M 38.32M 35.25M 66.07M 4.53B 67.35M 457M 179M 2.22B 176M 172M 7.68B | 38.73M 34.04M 31.63M 29.09M 54.53M 3.74B 55.59M 377M 147M 1.83B 145M 142M 6.34B |
| Net income | 6.7M 5.89M 5.47M 5.03M 9.44M 647M 9.62M 65.32M 25.5M 317M 25.16M 24.61M 1.1B | 24.58M 21.6M 20.07M 18.46M 34.6M 2.37B 35.27M 240M 93.51M 1.16B 92.24M 90.25M 4.02B |
| Net Debt | 4.4M 3.86M 3.59M 3.3M 6.19M 424M 6.31M 42.84M 16.72M 208M 16.5M 16.14M 720M | -1.32M -1.16M -1.08M -993K -1.86M -128M -1.9M -12.89M -5.03M -62.47M -4.96M -4.85M -216M |
Employees
102
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/07/26 | US$1.450 | -3.97% | 2,536 |
| 22/07/26 | US$1.510 | +0.37% | 4,632 |
| 21/07/26 | US$1.504 | +0.97% | 1,217 |
| 20/07/26 | US$1.490 | -2.30% | 4,423 |
| 17/07/26 | US$1.525 | -1.61% | 2,060 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- IDXG Stock
Select your edition
All financial news and data tailored to specific country editions
